Zoetis Inc
(XTER:ZOE)
€
161.04
-7.48 (-4.47%)
Market Cap: 72.99 Bil
Enterprise Value: 77.63 Bil
PE Ratio: 34.28
PB Ratio: 15.16
GF Score: 96/100 Zoetis Inc at Bank of America Merrill Lynch Animal Health Summit Transcript
Feb 25, 2019 / 08:05PM GMT
Michael Leonidovich Ryskin
BofA Merrill Lynch, Research Division - Associate
Joining us is Glenn David, CFO of Zoetis. We're gonna start with just the fireside chat, and then open up for questions. So thank you for joining us.
Glenn C. David
Zoetis Inc. - Executive VP & CFO
Thank you for having me.
Questions & Answers
Michael Leonidovich Ryskin
BofA Merrill Lynch, Research Division - Associate
So just high level at the start, can you review 2018? It was a little bit of an eventful year, had a lot happened, so let's just go through the story over course of the year and where you ended.
Glenn C. David
Zoetis Inc. - Executive VP & CFO
Absolutely. So 2018 was a great year for us at Zoetis. So when you start with the top line, we're able to grow revenue at 10%. And part of that contribution was 2% from Abaxis, which was one of the big events that we had in 2018. With the acquisition of Abaxis, we're very excited about. Overall, though, our organic
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot